Flatiron Health, a pioneering oncology-focused health technology company, has joined forces with the Association of Cancer Care Centers (ACCC), a vast network of over 40,000 cancer care professionals, to revolutionize access to cancer clinical trials and empower healthcare providers through advanced data capture technology. With the integration of cutting-edge tools and a collaborative approach, this partnership seeks to transform the way clinical trials are conducted, making them more accessible and inclusive for patients in various settings. This endeavor is particularly crucial as it addresses the prevalent issue of disparities in clinical trial participation, aiming to offer lifesaving treatment options and fostering inclusivity in cancer research and treatment. The collaboration underscores a concerted effort to leverage technology for the betterment of patient outcomes and efficiency in oncology care practices.
Enhanced Access to Clinical Trials for Community-Based Patients
A cornerstone objective of the collaboration between Flatiron Health and ACCC is to significantly enhance access to clinical trials for patients receiving care in community-based settings. By promoting participation in these trials, the partnership seeks to provide patients with access to cutting-edge and potentially lifesaving treatment options closer to their homes. This initiative is vital in reducing the existing disparities in clinical trial participation, which often limit the reach to more diverse patient populations. Broader access invites a more inclusive demographic, thereby enriching the data and findings garnered from these trials, which ultimately benefits the wider cancer patient community.
Flatiron Health’s innovative Flatiron Clinical Pipe™ technology plays an instrumental role in this initiative. This advanced tool connects electronic health records (EHR) to electronic data capture (EDC) systems, facilitating a more streamlined and precise data collection process. By supporting the seamless transfer of both structured and unstructured clinical trial data, Flatiron Clinical Pipe™ ensures a significant reduction in the administrative workload for ACCC member practices. The technological efficiency frees up valuable staff time, allowing healthcare providers to dedicate more attention to patient care. As a result, these practices can engage in an increased number of clinical trials, thus expanding the availability of experimental treatments to a larger patient base.
Revolutionizing Data Management and Patient Care
The collaboration between Flatiron Health and ACCC is set to revolutionize data management and patient care within cancer treatment facilities. By incorporating Flatiron Clinical Pipe™, data capture is enhanced, leading to a more precise and accelerated process which benefits both clinicians and patients. This streamlined approach minimizes the potential for errors and redundancy, thereby enhancing the quality and reliability of the data collected in clinical trials. Moreover, the reduction in administrative overheads translates into more efficient operations, enabling practices to participate in a larger number of clinical trials without overburdening their resources.
Sumanta K. Pal, MD, FASCO, Chair of ACCC’s Community Oncology Research Institute (ACORI), underscores the significance of this partnership by emphasizing the integration of advanced technology in community cancer centers. By making clinical trials more accessible and managing data more effectively, patient care quality is consequently enhanced. The strategic use of technology not only improves resource allocation and operational efficiency but also ensures that more patients can benefit from the latest treatments available through clinical trials. This advancement in data management is pivotal in offering high-quality care and fostering an environment of continuous improvement and innovation in cancer research.
Creating an Inclusive and Efficient Cancer Trial Ecosystem
The partnership between Flatiron Health and ACCC is poised to revolutionize data management and patient care within cancer treatment centers. With the adoption of Flatiron Clinical Pipe™, data capture becomes more precise and faster, benefiting both clinicians and patients. This streamlined process reduces errors and redundancy, thereby improving the quality and reliability of data in clinical trials. Additionally, the decrease in administrative overhead allows for more efficient operations, enabling practices to engage in a greater number of clinical trials without overextending their resources.
Sumanta K. Pal, MD, FASCO, Chair of ACCC’s Community Oncology Research Institute (ACORI), highlights the importance of this collaboration, emphasizing the integration of advanced technology in community cancer centers. By making clinical trials more accessible and effectively managing data, patient care quality is significantly enhanced. The strategic utilization of technology not only improves resource allocation and operational efficiency but also ensures that more patients can benefit from the latest treatments available through clinical trials. This advancement is crucial in offering high-quality care and fostering continuous improvement and innovation in cancer research.